Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Zhuang, Sen Hong"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł :
Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies.
Autorzy :
Gayko, Urte
Fung, Mann
Clow, Fong
Sun, Steven
Faust, Elizabeth
Price, Samiyeh
James, Danelle
Doyle, Margaret
Bari, Samina
Zhuang, Sen Hong
Pokaż więcej
Temat :
PROTEIN-tyrosine kinase inhibitors
B cell lymphoma
MANTLE cell lymphoma
CHRONIC lymphocytic leukemia
WALDENSTROM'S macroglobulinemia
CHEMOTHERAPY (Cancer)
Źródło :
Annals of the New York Academy of Sciences; Nov2015, Vol. 1358 Issue 1, p82-94, 13p
Czasopismo naukowe
Tytuł :
Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.
Autorzy :
Orlowski, Robert
Sutherland, Heather
Bladé, Joan
Miguel, Jesús San
Hájek, Roman
Nagler, Arnon
Sonneveld, Pieter
Spencer, Andrew
Robak, Tadeusz
Mundle, Suneel
Luo, Donghan
Zhuang, Sen Hong
Harousseau, Jean-Luc
Pokaż więcej
Źródło :
Blood; November 2007, Vol. 110 Issue: 11 p2735-2735, 1p
Periodyk
Tytuł :
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Autorzy :
Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA.
Madduri D; Mount Sinai Medical Center, New York, NY, USA.
Usmani SZ; Levine Cancer Institute-Atrium Health, Charlotte, NC, USA.
Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.
Agha M; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Stewart AK; University Health Network and the Princess Margaret Cancer Centre, Toronto, ON, Canada.
Hari P; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Htut M; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Lesokhin A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Deol A; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Munshi NC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
O'Donnell E; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Avigan D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Singh I; Janssen Research and Development, Spring House, PA, USA.
Zudaire E; Janssen Research and Development, Spring House, PA, USA.
Yeh TM; Janssen Research and Development, Raritan, NJ, USA.
Allred AJ; Janssen Research and Development, Spring House, PA, USA.
Olyslager Y; Janssen Research and Development, Beerse, Belgium.
Banerjee A; Janssen Research and Development, Spring House, PA, USA.
Jackson CC; Janssen Research and Development, Raritan, NJ, USA.
Goldberg JD; Janssen Research and Development, Raritan, NJ, USA.
Schecter JM; Janssen Research and Development, Raritan, NJ, USA.
Deraedt W; Janssen Research and Development, Beerse, Belgium.
Zhuang SH; Janssen Research and Development, Raritan, NJ, USA.
Infante J; Janssen Research and Development, Raritan, NJ, USA.
Geng D; Legend Biotech USA, Piscataway, NJ, USA.
Wu X; Legend Biotech USA, Piscataway, NJ, USA.
Carrasco-Alfonso MJ; Legend Biotech USA, Piscataway, NJ, USA.
Akram M; Legend Biotech USA, Piscataway, NJ, USA.
Hossain F; Legend Biotech USA, Piscataway, NJ, USA.
Rizvi S; Legend Biotech USA, Piscataway, NJ, USA.
Fan F; Nanjing Legend Biotechnology, Nanjing, China.
Lin Y; Mayo Clinic, Rochester, MN, USA.
Martin T; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Jagannath S; Mount Sinai Medical Center, New York, NY, USA. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 314-324. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
B-Cell Maturation Antigen/*administration & dosage
Immunotherapy, Adoptive/*methods
Multiple Myeloma/*drug therapy
Receptors, Chimeric Antigen/*administration & dosage
Aged ; Female ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; United States
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies